This site is intended for health professionals only!

GSK in $40m China investment


GlaxoSmithKline intends to spend $40m this year on its new facility in Shanghai, China, which is expected to become one of the drug major

Most read

Latest Issue

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine